i accept that the "proceeding" to which o 15a r 3 refers is a proceeding for final relief.
notwithstanding this, the department has given evidence that it could give effect to an injunction as late as 31 july 2009, preventing a listing of the generics on the pbs on the following day, 1 august 2009.
under the relevant provisions of the national health act 1953 (cth), the effect of a listing of the generics on the pbs will be to apply a 12.5% price reduction to the generics and to the three varieties of efexor-xr marketed by wyeth.